Jpmorgan Chase & CO Da32 Life Science Tech Acquisition Corp. Transaction History

Jpmorgan Chase & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$9.94 - $10.2 $1.74 Million - $1.78 Million	175,000 Added 233.33%	250,000 $2.53 Million
Q4 2022 Feb 13, 2023	SELL	$9.73 - $10.08 $238,385 - $246,960	-24,500 Reduced 24.62%	75,000 $750,000
Q3 2022 Nov 14, 2022	SELL	$9.68 - $9.79 $488,840 - $494,394	-50,500 Reduced 33.67%	99,500 $964,000
Q1 2022 May 11, 2022	SELL	$9.59 - $9.81 $1.33 Million - $1.36 Million	-139,000 Reduced 48.1%	150,000 $1.46 Million
Q4 2021 Feb 10, 2022	SELL	$9.68 - $9.96 $100,178 - $103,076	-10,349 Reduced 3.46%	289,000 $2.84 Million
Q3 2021 Nov 12, 2021	BUY	$9.76 - $10.26 $2.92 Million - $3.07 Million	299,349 New	299,349 $2.94 Million

Ticker DALS
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 20,650,000
Description
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.